Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia.
Abstract BCR-ABL tyrosine kinase inhibitors (TKIs) are selective therapies for the patients with Chronic Myeloid Leukemia (CML). Imatinib and ponatinib have remarkable long-term efficacy on a major molecular response. Although…